Physician profile
Allison E Lied
NPI 1992743272
$3,410.09
in general payments reported to CMS, 2019-2025
11 companies · $701 in 2025
The $701 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,431 · 2020: $23.80 · 2021: $161 · 2022: $172 · 2023: $304 · 2024: $617 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,621.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,118.95 | 2019 | |
| Abbvie INC. | $861.95 | 2023-2025 | |
| Galderma Laboratories, L.P. | $512.86 | 2019-2025 | Dysport |
| Mentor Worldwide LLC | $250.31 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Allergan, INC. | $182.65 | 2019-2022 | |
| Revance Therapeutics, INC. | $127.97 | 2024-2025 | Daxxify |
| Musculoskeletal Transplant Foundation INC. | $120.31 | 2019 | |
| Merz North America, INC. | $101.16 | 2019-2021 | |
| Sientra, INC. | $94.32 | 2021 | |
| Solventum Corporation | $27.29 | 2025 | Prevena |
| Acacia Pharma INC | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Lied listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.